Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-09

Clinical Trial Update: A Study Evaluating Chemotherapy With Fractionated Cisplatin/Gemcitabine Versus Carboplatin/Gemcitabine in the Treatment of Advanced or Metastatic Urothelial Cancer With Impaired Renal Function. [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial comparing fractionated cisplatin/gemcitabine versus carboplatin/gemcitabine in advanced or metastatic urothelial cancer with impaired renal fu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPLATIN (Carboplatin)
  • CISPLATIN (cisplatin)
  • Gemcitabine (Gemcitabine)

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Advanced Urothelial Cancer, Metastatic Urothelial Cancer | Phase 2, Phase 3 | Status: COMPLETED